Instruction for use: Flutamide STADA

Active substance: Flutamide

ATX code L02BB01 Flutamide

Pharmacological group

Androgens, antiandrogens

Antineoplastic hormonal agents and hormone antagonists

Composition

Tablets 1 table.

Flutamide 250 mg

Auxiliary substances: MCC; corn starch; Sodium laurisulfate; Lactose monohydrate; Silica anhydrous; Magnesium stearate

In a blister of 21 pcs .; In the box 1 or 4 blisters.

pharmachologic effect

Pharmacological action - antiandrogenic, antitumor.

Dosing and Administration

Inside, not liquid, squeezed water, preferably after eating, 1 table. 3 times a day (corresponding to a daily dose of 750 mg).

When combined treatment: it is recommended to start the initial treatment with Flutamide STADA at least 3 days before the start of therapy with the agonist LH-releasing hormone (LHRH) to reduce the degree of exacerbation of the disease.

With impaired liver function, long-term treatment with flutamide should be prescribed only after a thorough evaluation of the benefits and risks.

Be wary appoint patients with impaired renal function.

Duration of treatment is determined by the attending physician taking into account the nature, severity and course of the disease.

storage Conditions

At a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Shelf life

5 years.

Do not use after the expiry date printed on the package.